Drug Shortage Report for APO-AMOXI

Last updated on 2024-02-14 History
Report ID 162918
Drug Identification Number 00628158
Brand name APO-AMOXI
Common or Proper name AMOXICILLAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100mL and 150mL
ATC code J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-06-15
Estimated end date 2023-10-13
Actual end date 2023-10-05
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v41 2024-02-14 English Compare
v40 2023-10-06 English Compare
v39 2023-09-28 French Compare
v38 2023-09-28 English Compare
v37 2023-07-27 French Compare
v36 2023-07-27 English Compare
v35 2023-06-23 French Compare
v34 2023-06-23 English Compare
v33 2023-05-26 French Compare
v32 2023-05-26 English Compare
v31 2023-04-06 French Compare
v30 2023-04-06 English Compare
v29 2023-02-16 French Compare
v28 2023-02-16 English Compare
v27 2023-01-06 French Compare
v26 2023-01-06 English Compare
v25 2022-12-03 French Compare
v24 2022-12-03 English Compare
v23 2022-11-18 English Compare
v22 2022-11-18 English Compare

Showing 1 to 20 of 41